Inventor
OSTERTAG ERIC M
US19 patents
⚠️ This page may combine multiple inventors who share the name “OSTERTAG ERIC M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
POSEIDA THERAPEUTICS INC
12 patentsUS10415024B2Sep 17, 2019
Site-specific enzymes and methods of use
POSEIDA THERAPEUTICS INC25 citations90
US11802269B2Oct 31, 2023
Superpiggybac transposase compositions
POSEIDA THERAPEUTICS INC1 citations72
US11718656B2Aug 8, 2023
Inducible caspases and methods for use
POSEIDA THERAPEUTICS INC1 citations72
US11377480B2Jul 5, 2022
Inducible caspases and methods for use
POSEIDA THERAPEUTICS INC2 citations72
US11485959B2Nov 1, 2022
Hyperactive piggybac transposases
POSEIDA THERAPEUTICS INC1 citations71
US12415844B2Sep 16, 2025
BCMA specific VCAR compositions and methods for use
POSEIDA THERAPEUTICS INC1 citations63
US12358966B2Jul 15, 2025
Inducible caspases and methods for use
POSEIDA THERAPEUTICS INC0 citations61
US10844361B2Nov 24, 2020
Site-specific enzymes and methods of use
POSEIDA THERAPEUTICS INC1 citations58
US11744861B2Sep 5, 2023
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
POSEIDA THERAPEUTICS INC0 citations55
US12385061B2Aug 12, 2025
Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression
POSEIDA THERAPEUTICS INC0 citations51
US10131634B2Nov 20, 2018
Method of treating pain
POSEIDA THERAPEUTICS INC1 citations50
US12540335B2Feb 3, 2026
Compositions and methods for the treatment of metabolic liver disorders
POSEIDA THERAPEUTICS INC0 citations45
OSTERTAG ERIC M
3 patentsUS8722964B2May 13, 2014
Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
OSTERTAG ERIC M11 citations81
US8558055B2Oct 15, 2013
Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
OSTERTAG ERIC M16 citations81
US9314005B2Apr 19, 2016
Genetically modified rat models for severe combined immunodeficiency (SCID)
OSTERTAG ERIC M7 citations80
HERA TESTING LABORATORIES INC
3 patentsUS11089765B2Aug 17, 2021
Genetically modified rat models for severe combined immunodeficiency (SCID)
HERA TESTING LABORATORIES INC2 citations68
US12274247B2Apr 15, 2025
Genetically modified rat models for severe combined immunodeficiency (SCID)
HERA TESTING LABORATORIES INC0 citations58
US11849709B2Dec 26, 2023
Genetically modified rat models for severe combined immunodeficiency (SCID)
HERA TESTING LABORATORIES INC0 citations58